MUC1 and COVID-19: Since COVID-19 is still a global threat to health systems due to the associated morbidity, hospitalization risk and mortality, the aim of the present study was to investigate the performance of serum MR-proADM, alone and combined with KL-6 and IL-6, in predicting in-hospital mortality and the need for invasive respiratory support on admission to hospital.